Dow Up0.11% Nasdaq Up0.50%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
6.22 Up 0.21(3.49%) Aug 29, 4:00PM EDT
|After Hours : 6.21 Down 0.01 (0.16%) Aug 29, 4:49PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 28,631   26,947   26,746   21,653  
Cost of Revenue1,689  1,370  1,292  1,222  
Gross Profit 26,941   25,577   25,454   20,431  
Operating Expenses
Research Development12,300  9,892  9,525  27,930  
Selling General and Administrative26,533  27,460  25,925  26,998  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,892) (11,775) (9,997) (34,498)
Income from Continuing Operations
Total Other Income/Expenses Net5  (4)5  7  
Earnings Before Interest And Taxes(11,887)(11,779)(9,992)(34,490)
Interest Expense812  898  955  955  
Income Before Tax(12,699)(12,678)(10,947)(35,445)
Income Tax Expense -   -   -  3  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,699)(12,678)(10,947)(35,448)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,699) (12,678) (10,947) (35,448)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,699) (12,678) (10,947) (35,448)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.